Advanced Sterilization Products (ASP) Announces CE Mark for ULTRA GI™ Cycle for Duodenoscopes in Partnership with FUJIFILM Healthcare Europe
Advanced Sterilization Products (FTV) announced on Jan 15, 2026 that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology received CE mark approval in partnership with FUJIFILM Healthcare Europe.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Advanced Sterilization Products (FTV) announced on Jan 15, 2026 that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology received CE mark approval in partnership with FUJIFILM Healthcare Europe. The cycle adds hydrogen peroxide gas plasma sterilization for duodenoscopes, including compatibility for FUJIFILM models ED-840T and ED-840XT. Existing STERRAD 100NX customers can obtain the ULTRA GI Cycle via a cycle upgrade on installed equipment, while ASP will work with device makers to design future duodenoscopes for hydrogen peroxide compatibility. The move aims to strengthen reprocessing confidence and patient safety across European healthcare settings.
Positive
- ULTRA GI Cycle received CE mark approval (Jan 15, 2026)
- Adds hydrogen peroxide gas plasma sterilization for duodenoscopes
- FUJIFILM models ED-840T and ED-840XT added to approved cycle
- Existing STERRAD 100NX units eligible for cycle upgrade
Negative
- Approval is limited to CE mark jurisdiction—Europe
- Requires duodenoscopes to be designed for hydrogen peroxide compatibility
Details
News Market Reaction – FTV
On Jan 15, the day this news came out, FTV closed 0.45% below the previous close.
Data tracked by StockTitan Argus for the Jan 15 session.
Key Figures
- STERRAD 100NX model
- 100NX
- Model designation of the STERRAD 100NX Sterilizer mentioned in the release
Historical Context
-
Scheduled Q4 2025 earnings webcast and provided access details for investors.
-
Board appointment at Tolion Health AI highlighting director’s roles including Fortive.
-
Launch of CalStudio SaaS calibration-management platform under Fluke (FTV).
-
CEO presentation announcement for Baird 2025 Global Industrial Conference.
-
Fluke survey on unplanned downtime costs and vulnerabilities in manufacturing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
ce mark regulatory
duodenoscopes medical
hydrogen peroxide gas plasma sterilization medical
reprocessing medical
infection control medical
contamination rates medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
New cycle for the STERRAD™ 100NX Sterilizer expands sterilization options, enhances reprocessing confidence, and promotes patient safety.
The ULTRA GI™ Cycle's receipt of the CE mark represents a pivotal advancement in elevating patient safety across healthcare facilities and addressing the complex challenges associated with traditional reprocessing methods. "This is a meaningful step forward in our mission to make duodenoscope reprocessing safer across
Pierre Emeric, Vice President, R&D at ASP continued, "The addition of the new FUJIFILM duodenoscope models ED-840T and ED-840XT to the ULTRA GI Cycle further expands the breakthrough technology platform and demonstrates ASP's commitment to innovation and partnership with FUJIFILM Healthcare. Most importantly, current ASP customers who already have a STERRAD 100NX Sterilizer with ALLClear Technology can access the benefits of the ULTRA GI Cycle via a cycle upgrade on their existing equipment and can continue maximizing the value of their investment."
"Duodenoscopes have historically posed infection control challenges due to their contamination rates," said Ivan Salgo, MD, VP & Chief Medical Officer at ASP. "The partnership between ASP and FUJIFILM Healthcare has resulted in a sterilization approach that exceeds current industry benchmarks, providing healthcare professionals with an advanced solution to elevate patient safety standards."
Visit this webpage for more information on the ULTRA GI™ Cycle.
For media inquiries or further information, please contact:
MEDIA CONTACT:
Nuno Azeredo
Vice President, Global Brand Marketing
Advanced Sterilization Products (ASP)
asp-communications@asp.com
INVESTOR RELATIONS:
Christina Jones
Vice President, Investor Relations
Fortive Corporation
investors@fortive.com
About Advanced Sterilization Products (ASP)
Advanced Sterilization Products (ASP) has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health care and safety for those who matter most. Our pioneering technology, global distribution and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day for thousands of medical facilities around the world. This enables our customers to focus on what they do best – preventing infection and saving lives. For more information, please visit www.asp.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/advanced-sterilization-products-asp-announces-ce-mark-for-ultra-gi-cycle-for-duodenoscopes-in-partnership-with-fujifilm-healthcare-europe-302661858.html
SOURCE Advanced Sterilization Products (ASP)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.